You haven't searched anything yet.
POSITION SUMMARY:
The Executive Director, Global Clinical Operations will report to the CMO and Executive VP and function as a strategic leader of the Clinical Operations group, accountable for key high-level management, establishing new processes and procedures, and adherence to industry best practices, Rigel SOPs, and applicable regulations and Good Clinical Practice (GCP). The Executive Director maintains oversight of the operation of all clinical programs including project planning, budget, resource management, and management of contract research organizations (CROs) and other key vendors. This individual represents departmental and corporate management to ensure appropriate fiscal oversight, including management of vendor scopes-of-work and change orders, and recommends and implements innovative ideas to impact clinical trials management. The Executive Director oversees clinical trials staff both internally and at service providers and manages all aspects of study operations at both the project and the department levels. As a member of the Development Senior Leadership Team, this role acts as a cross-functional leader to ensure study plans appropriately support research questions and other goals of the company and participates in development-wide discussions to resolve differences with other functional areas within Development. The Executive Director ensures a positive, collaborative team environment and escalates issues to the CMO and Executive VP, and other functional area Heads as appropriate.
ESSENTIAL DUTIES AND RESPONSIBILITIES:
KNOWLEDGE AND SKILL REQUIREMENTS:
WORKING CONDITIONS:
Rigel Pharmaceuticals, Inc. is an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, genetic information, national origin, protected veteran status, disability status, or any othercharacteristic protected by the law.
Full Time
$199k-242k (estimate)
03/21/2024
05/20/2024